A detailed history of Rubric Capital Management LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Rubric Capital Management LP holds 16,005,498 shares of TEVA stock, worth $273 Million. This represents 8.03% of its overall portfolio holdings.

Number of Shares
16,005,498
Previous 17,261,741 7.28%
Holding current value
$273 Million
Previous $281 Million 2.82%
% of portfolio
8.03%
Previous 8.31%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.81 - $18.96 $19.9 Million - $23.8 Million
-1,256,243 Reduced 7.28%
16,005,498 $288 Million
Q2 2024

Aug 13, 2024

SELL
$12.78 - $17.4 $5.21 Million - $7.1 Million
-407,847 Reduced 2.31%
17,261,741 $281 Million
Q1 2024

May 10, 2024

SELL
$10.67 - $14.43 $5.94 Million - $8.04 Million
-557,013 Reduced 3.06%
17,669,588 $249 Million
Q4 2023

Feb 13, 2024

SELL
$8.12 - $10.63 $6.28 Million - $8.22 Million
-773,399 Reduced 4.07%
18,226,601 $190 Million
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $2.11 Million - $3.01 Million
281,638 Added 1.5%
19,000,000 $194 Million
Q2 2023

Aug 11, 2023

BUY
$7.2 - $9.47 $102 Million - $135 Million
14,218,556 Added 315.98%
18,718,362 $141 Million
Q1 2023

May 12, 2023

BUY
$8.36 - $11.37 $37.6 Million - $51.2 Million
4,499,806 New
4,499,806 $39.8 Million
Q1 2019

May 10, 2019

SELL
$15.58 - $20.01 $12.9 Million - $16.6 Million
-830,000 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $12.1 Million - $19.8 Million
830,000 New
830,000 $12.8 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.